Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer
Seung-Hyun Shin, Iljin Kim, Jae Eun Lee, Mingyu Lee, Jong‐Wan Park
Topics & Concepts
Prostate cancerMetastasisCancer researchBiologyCancerEpithelial–mesenchymal transitionProstateChromoplexyTumor progressionOncologyTranscription factorCarcinogenesisMetastasis Suppressor GeneInternal medicineGenePCA3MedicineGeneticsProstate Cancer Treatment and ResearchCancer-related gene regulationRadiopharmaceutical Chemistry and Applications